Delivery Order SPE2DB25D3306-SPE2DB25FUCRB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,905.14 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded September 26, 2025, represents a non-competitive, non-set-aside procurement with a completion deadline of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector on August 13, 2025, with a ceiling value of $22,839.45. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. TALTZ is a biologic immunosuppressant used...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.62 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 7, 2025, with ultimate completion by August 8, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat autoimmune conditions, and this procurement represents a routine...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,562.85 on September 24, 2025, for TALTZ 80 mg/mL auto-injectors. This firm fixed-price, competitively awarded contract is not set-aside and represents a child order under a larger indefinite delivery contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with completion expected by September 25, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a $18,151.80 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with a completion date of September 8, 2025. The contract was competitively awarded on September 5, 2025, with no set-aside designation, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCRBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,302.89 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ is a biologic medication used to treat inflammatory conditions, and this order represents a continuation of the company's established role as a critical pharmaceutical supplier within the federal medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and one of the DLA's primary vendors, AmerisourceBergen maintains an extensive portfolio of federal contracts supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide and other government healthcare entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 8/18/25 |